Psyence Company Top Insiders
| PSYGF Stock | USD 0.13 0.00 0.00% |
Psyence employs about 10 people. The company is managed by 10 executives with a total tenure of roughly 24 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Examination of Psyence's management performance can provide insight into the company performance.
| BCom Bcomm Insider CoFounder Director |
| Taryn Vos Insider G Counsel |
Psyence |
Psyence Management Team Effectiveness
The company has return on total asset (ROA) of (0.7448) % which means that it has lost $0.7448 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.6611) %, meaning that it generated substantial loss on money invested by shareholders. Psyence's management efficiency ratios could be used to measure how well Psyence manages its routine affairs as well as how well it operates its assets and liabilities.Psyence owns a total of 93.28 Million outstanding shares. Psyence holds 10.8 pct. of its outstanding shares held by insiders and 0.0 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Psyence in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Psyence, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Psyence Workforce Comparison
Psyence Group is considered to be number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers—General industry is at this time estimated at about 104. Psyence holds roughly 10.0 in number of employees claiming about 10% of equities under Drug Manufacturers—General industry.
Psyence Group Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Psyence Group Price Series Summation is a cross summation of Psyence price series and its benchmark/peer.
Psyence Notable Stakeholders
A Psyence stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Psyence often face trade-offs trying to please all of them. Psyence's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Psyence's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| BCom Bcomm | CoFounder Director | Profile | |
| Taryn Vos | G Counsel | Profile | |
| Jody Aufrichtig | CoFounder Chairman | Profile | |
| Neil MD | Chief Officer | Profile | |
| Mike Dacks | Chief Officer | Profile | |
| BSc MD | Chief Jamaica | Profile | |
| Amza MD | Director Officer | Profile | |
| MaryElizabeth Gifford | Exec Responsibility | Profile | |
| Warwick CordenLloyd | CFO Sec | Profile |
About Psyence Management Performance
The success or failure of an entity such as Psyence Group often depends on how effective the management is. Psyence management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Psyence management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Psyence management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities. Psyence Group Inc. was founded in 2019 and is based in Toronto, Canada. Psyence is traded on OTC Exchange in the United States.
Psyence Workforce Analysis
Traditionally, organizations such as Psyence use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Psyence within its industry.Psyence Manpower Efficiency
Return on Psyence Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 460.1K | |
| Net Loss Per Executive | 460.1K |
Complementary Tools for Psyence Pink Sheet analysis
When running Psyence's price analysis, check to measure Psyence's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psyence is operating at the current time. Most of Psyence's value examination focuses on studying past and present price action to predict the probability of Psyence's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psyence's price. Additionally, you may evaluate how the addition of Psyence to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |